You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
The possible clinical outcome pathways include:
1.
The drug acamprosate targets the protein P14416 which is involved with (among others) the Myogenesis pathway and associated protein P01303 which is relevant to the female gonad and alleviates symptoms of Alcoholism. (Confidence 0.421015).
<snip>
From @dkoslicki on November 26, 2017 23:9
Since I don't have any "ground truth" for these, those with more bio knowledge, please make sure they look plausible/are correct.
You can run it yourself on all Q2 drugs/diseases via:
Copied from original issue: dkoslicki/NCATS#107
The text was updated successfully, but these errors were encountered: